{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:17:38Z","timestamp":1777969058944,"version":"3.51.4"},"reference-count":28,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15549","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:47:24Z","timestamp":1774511244000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["A rare case of uterine carcinosarcoma in a 21\u2011year\u2011old woman with hereditary breast and ovarian cancer syndrome: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Yasushi","family":"Iida","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayane","family":"Kosuge","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dokkyo Medical University, Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takakura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343\u20118555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"key20260505102847_b1-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/jnci\/djab036","article-title":"Endometrial cancer risk in women with germline BRCA1 or BRCA2 mutations: Multicenter cohort study","volume":"113","author":"de Jonge","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"key20260505102847_b2-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20260505102847_b3-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/cncr.31842","article-title":"Uterine cancer in Jewish Israeli BRCA1\/2 mutation carriers","volume":"125","author":"Laitman","year":"2019","journal-title":"Cancer"},{"key":"key20260505102847_b4-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ygyno.2020.11.034","article-title":"Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1\/2 mutated patients- A systematic review and meta-analysis","volume":"160","author":"Nahshon","year":"2021","journal-title":"Gynecol Oncol"},{"key":"key20260505102847_b5-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"key20260505102847_b6-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/ijgc-2022-004073","article-title":"Endometrial carcinosarcoma","volume":"33","author":"Bogani","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"key20260505102847_b7-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"1505504","DOI":"10.3389\/fonc.2025.1505504","article-title":"Uterine carcinosarcoma with heterologous osseous elements: A case report of an extremely rare clinical occurrence with literature review","volume":"15","author":"Al Dallal","year":"2025","journal-title":"Front Oncol"},{"key":"key20260505102847_b8-ol-31-5-15549","first-page":"e12642","article-title":"Uterine carcinosarcoma in a young female: Case report and literature review","volume":"13","author":"Soror","year":"2021","journal-title":"Cureus"},{"key":"key20260505102847_b9-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1658-3876(10)50027-X","article-title":"Carcinosarcoma of the uterus in a woman with down syndrome","volume":"3","author":"Al-Badawi","year":"2010","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"key20260505102847_b10-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"key20260505102847_b11-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"key20260505102847_b12-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s12253-020-00829-9","article-title":"TCGA classification of endometrial cancer: The place of carcinosarcoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"key20260505102847_b13-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijgo.13937","article-title":"Prognostic value of the TCGA molecular classification in uterine carcinosarcoma","volume":"158","author":"Travaglino","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"key20260505102847_b14-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.3802\/jgo.2022.33.e29","article-title":"Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset","volume":"33","author":"Hong","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"key20260505102847_b15-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20260505102847_b16-ol-31-5-15549","first-page":"5952","article-title":"Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma","volume":"18","author":"Akiyama","year":"2019","journal-title":"Oncol Lett"},{"key":"key20260505102847_b17-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ygyno.2024.12.012","article-title":"Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma","volume":"193","author":"Toboni","year":"2025","journal-title":"Gynecol Oncol"},{"key":"key20260505102847_b18-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ygyno.2023.04.024","article-title":"Germline drivers of gynecologic carcinosarcomas","volume":"174","author":"Sia","year":"2023","journal-title":"Gynecol Oncol"},{"key":"key20260505102847_b19-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/djad016","article-title":"Comprehensive analysis of germline drivers in endometrial cancer","volume":"115","author":"Gordhandas","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"key20260505102847_b20-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1200\/JCO.21.02050","article-title":"Randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: An NRG oncology trial","volume":"40","author":"Powell","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20260505102847_b21-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1200\/JCO.2009.26.8326","article-title":"Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A gynecologic oncology group study","volume":"28","author":"Powell","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20260505102847_b22-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2020.10.043","article-title":"Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity","volume":"160","author":"Matsuzaki","year":"2021","journal-title":"Gynecol Oncol"},{"key":"key20260505102847_b23-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41467-017-00388-9","article-title":"BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers","volume":"8","author":"Maxwell","year":"2017","journal-title":"Nat Commun"},{"key":"key20260505102847_b24-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov"},{"key":"key20260505102847_b25-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20260505102847_b26-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep"},{"key":"key20260505102847_b27-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.23.02132","article-title":"Durvalumab plus carboplatin\/paclitaxel followed by maintenance durvalumab with or without olaparib as first-line treatment for advanced endometrial cancer: The phase III DUO-E trial","volume":"42","author":"Westin","year":"2024","journal-title":"J Clin Oncol"},{"key":"key20260505102847_b28-ol-31-5-15549","doi-asserted-by":"publisher","first-page":"1612716","DOI":"10.3389\/fonc.2025.1612716","article-title":"A rare case report of uterine carcinosarcoma with bilateral ovarian brenner tumors","volume":"15","author":"Wan","year":"2025","journal-title":"Front Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:28:53Z","timestamp":1777966133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15549","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}